Get started
Author

M.A. Gambacorta

Innovative radiotherapy approaches
2025 · G. Chiloiro, P. Franco, et al. · ESMO Gastrointestinal Oncology · 3
PDF
Correlation between radiation dose to bone marrow subregions and acute hematologic toxicity inendometrial cancer treated with external beam radiotherapy
2025 · R. Autorino, D. Cusumano, et al. · Clinical and Translational Radiation Oncology · 3
PDF
OC-0463 AI surpassing human expert: a multi-centric evaluation for organ at risk delineation
2022 · D. Azria, L. Boldrini, et al. · Radiotherapy and Oncology · 1
PO-1123 Unconventional treatment in GBM with pseudoprogression: low-dose radiotherapy could be an option?
2022 · F. Beghella Bartoli, A. Nardangeli, et al. · Radiotherapy and Oncology · 1
ESTRO consensus recommendations: target volume and organ at risk delineation in rectal endoluminal high dose rate brachytherapy
2026 · A.C. Valkenburg, E.J. Van Limbergen, et al. · Clinical and Translational Radiation Oncology
PDF
Characterisation of an Mri Toolkit for 0.35 T Mr-linac Online Adaptive Workflows: Repeatable Quantitative Dwi/ Ivim and Geometric Accuracy
2026 · M. Nardini, K. Zormpas-Petridis, et al. · Physica Medica
Image-guided interventional radiotherapy (modern brachytherapy) for treatment of vaginal intraepithelial neoplasia: single-institution experience and systematic literature review and meta-analysis
2026 · V. Lancellotta, A. P. Solazzo, et al. · Strahlentherapie und Onkologie
PDF
P1.07.22 LANTERN1: AI Model for Postoperative Complications Prediction for NSCLC Lung Resection: Prospective Multicentric Study and Extern Validation
2025 · F. Lococo, C. Sassorossi, et al. · Journal of Thoracic Oncology
Pp06.06 Epid Based Psqa and In-vivo Dosimetry for Vmat Tbi Treatment Plan Using Commercial Tool
2024 · M. Galetto, G. Stimato, et al. · Physica Medica
1113: Stereotactic radiotherapy for liver oligometastases: a large real-world analysis
2024 · Pezzulla Donato, Elvira Maria Lima, et al. · Radiotherapy and Oncology
PO-1414 Adjuvant radiotherapy in endometrioid carcinoma with MELF pattern: a single-center experience
2023 · A. Nardangeli, R. Autorino, et al. · Radiotherapy and Oncology
PD-0812 Radiation Dose To Bone Marrow Subregions And Acute Hematologic Toxicity In Endometrial Cancer
2023 · R. Autorino, A. Nardangeli, et al. · Radiotherapy and Oncology
MO-0147 Plan library approach to optimize online adapted MRgRT workflow in cervical cancer patients
2023 · C. Votta, L. Boldrini, et al. · Radiotherapy and Oncology
Impact Of Body Composition Parameters From Simulation Ct-Scan On Neoadjuvant Chemoradiotherapy (Ncrt) Compliance And Survival In Locally Advanced Rectal Cancer (Larc) Patients: Preliminary Data Of A Large Retrospective Cohort Study
2023 · M. Cintoni, S. Reina, et al. · Clinical Nutrition ESPEN
PDF
PD-0827 Dose volume correlates of mouth opening reduction after radiotherapy for HNC: comprehensive analysis
2022 · M. Massaccesi, V. Fuga, et al. · Radiotherapy and Oncology
PO-1619 Clinical evaluation of novel DWI sequence on rectal cancer patients in a low tesla MR-Linac system
2022 · M. Nardini, A. Capotosti, et al. · Radiotherapy and Oncology
PO-1327 Fractal-based radiomic approach to tailor the chemotherapy treatment in rectal cancer
2022 · G. Chiloiro, C. Di Dio, et al. · Radiotherapy and Oncology
OC-0272 External validation of the Hemo-Eosinophils-Inflammation index as a prognosticator in anal cancer
2022 · P. Franco, A. Porreca, et al. · Radiotherapy and Oncology
MO-0650 Partial irradiation in cervical cancer MRgRT: a dosimetric evaluation
2022 · C. Votta, L. Boldrini, et al. · Radiotherapy and Oncology
OC-0260 Predictive value of inflammatory markers in LARC patients undergoing neoadjuvant chemoradiotherapy
2022 · S. Mariani, V. Chiloiro, et al. · Radiotherapy and Oncology
OC-0929 How to manage consolidative radiotherapy after HD methotrexate in PCNSL patients: a phase II study
2022 · S. Chiesa, F. Beghella Bartoli, et al. · Radiotherapy and Oncology
PO-1732 Advantages of low tesla MR-Linac advanced cost function for online adaptive dose optimization
2022 · L. Placidi, M. Nardini, et al. · Radiotherapy and Oncology
SP-1008 This house believes that short-course radiotherapy is the ideal schedule as part of total neoadjuvant therapy programs for rectal cancer Against the motion
2022 · M.A. Gambacorta · Radiotherapy and Oncology
PO-1317 Chemoradiotherapy-treated anal cancer patients radiomics-based stratification to predict DSS.
2022 · V. De Luca, L. Boldrini, et al. · Radiotherapy and Oncology
PO-1347 Which Is The Best Time To Assess Complete Response After Chemoradiation In Advanced Cervical Cancer?
2022 · R. Autorino, V. Lancellotta, et al. · Radiotherapy and Oncology
Works count: 34
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type